128 related articles for article (PubMed ID: 20653104)
41. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
42. Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.
Gozar MM; Muratova O; Keister DB; Kensil CR; Price VL; Kaslow DC
Exp Parasitol; 2001 Feb; 97(2):61-9. PubMed ID: 11281702
[TBL] [Abstract][Full Text] [Related]
43. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
Cao Y; Zhang DM; Pan WQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
[TBL] [Abstract][Full Text] [Related]
44. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
45. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
46. The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
Pinto VV; Salanti A; Joergensen LM; Dahlbäck M; Resende M; Ditlev SB; Agger EM; Arnot DE; Theander TG; Nielsen MA
Vaccine; 2012 Jan; 30(3):572-9. PubMed ID: 22122859
[TBL] [Abstract][Full Text] [Related]
47. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.
Jones GL; Spencer L; Lord R; Mollard R; Pye D; Saul A
Immunol Lett; 1990 Jul; 24(4):253-60. PubMed ID: 1697281
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits.
Halassy B; Vdović V; Habjanec L; Balija ML; Gebauer B; Sabioncello A; Santek T; Tomasić J
Vaccine; 2007 Apr; 25(17):3475-81. PubMed ID: 17239503
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice.
Babu JP; Pattnaik P; Gupta N; Shrivastava A; Khan M; Rao PV
Vaccine; 2008 Aug; 26(36):4655-63. PubMed ID: 18640168
[TBL] [Abstract][Full Text] [Related]
50. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant poly(N-isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis.
Verma R; Ravichandran R; Jayaprakash NS; Kumar A; Vijayalakshmi MA; Venkataraman K
Biotechnol J; 2015 May; 10(5):772-82. PubMed ID: 25641957
[TBL] [Abstract][Full Text] [Related]
52. Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.
Pattnaik P; Shakri AR; Singh S; Goel S; Mukherjee P; Chitnis CE
Vaccine; 2007 Jan; 25(5):806-13. PubMed ID: 17045706
[TBL] [Abstract][Full Text] [Related]
53. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
Brando C; Ware LA; Freyberger H; Kathcart A; Barbosa A; Cayphas S; Demoitie MA; Mettens P; Heppner DG; Lanar DE
Infect Immun; 2007 Feb; 75(2):838-45. PubMed ID: 17101665
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
Weiss R; Gabler M; Jacobs T; Gilberger TW; Thalhamer J; Scheiblhofer S
Vaccine; 2010 Jun; 28(28):4515-22. PubMed ID: 20438877
[TBL] [Abstract][Full Text] [Related]
55. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants.
Mojarab S; Shahbazzadeh D; Moghbeli M; Eshraghi Y; Bagheri KP; Rahimi R; Savoji MA; Mahdavi M
Microb Pathog; 2020 Mar; 140():103932. PubMed ID: 31857237
[TBL] [Abstract][Full Text] [Related]
56. Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.
Ringvall M; Huijbers EJ; Ahooghalandari P; Alekseeva L; Andronova T; Olsson AK; Hellman L
Vaccine; 2009 Dec; 28(1):48-52. PubMed ID: 19835827
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
Zhang D; Pan W
Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
[TBL] [Abstract][Full Text] [Related]
58. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
[TBL] [Abstract][Full Text] [Related]
59. A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.
Shahabi S; Azizi H; Mazloomi E; Tappeh KH; Seyedi S; Mohammadzadeh H
Immunol Invest; 2014; 43(7):653-66. PubMed ID: 25020077
[TBL] [Abstract][Full Text] [Related]
60. Immune responses and side effects of five different oil-based adjuvants in mice.
Leenaars M; Koedam MA; Hendriksen CF; Claassen E
Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
